Akos Heinemann
Akos Heinemann
Verified email at - Homepage
Cited by
Cited by
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 176, S21-S141, 2019
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 178, S27-S156, 2021
Uremia alters HDL composition and function
M Holzer, R Birner-Gruenberger, T Stojakovic, D El-Gamal, V Binder, ...
Journal of the American Society of Nephrology: JASN 22 (9), 1631, 2011
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
NAB Balenga, E Aflaki, J Kargl, W Platzer, R Schröder, S Blättermann, ...
Cell research 21 (10), 1452-1469, 2011
Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques
S Demyanets, V Konya, SP Kastl, C Kaun, S Rauscher, A Niessner, ...
Arteriosclerosis, thrombosis, and vascular biology 31 (9), 2080-2089, 2011
Psoriasis alters HDL composition and cholesterol efflux capacity [S]
M Holzer, P Wolf, S Curcic, R Birner-Gruenberger, W Weger, M Inzinger, ...
Journal of lipid research 53 (8), 1618-1624, 2012
Protein carbamylation renders high-density lipoprotein dysfunctional
M Holzer, M Gauster, T Pfeifer, C Wadsack, G Fauler, P Stiegler, ...
Antioxidants & redox signaling 14 (12), 2337-2346, 2011
E-type prostanoid receptor 4 (EP4) in disease and therapy
V Konya, G Marsche, R Schuligoi, A Heinemann
Pharmacology & therapeutics 138 (3), 485-502, 2013
The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study
GJ Sturm, E Böhm, M Trummer, I Weiglhofer, A Heinemann, W Aberer
Allergy 59 (10), 1110-1117, 2004
Inhibition of autophagy rescues palmitic acid-induced necroptosis of endothelial cells
MJ Khan, MR Alam, M Waldeck-Weiermair, F Karsten, L Groschner, ...
Journal of Biological Chemistry 287 (25), 21110-21120, 2012
The basophil activation test in the diagnosis of allergy: technical issues and critical factors
GJ Sturm, B Kranzelbinder, EM Sturm, A Heinemann, A Groselj‐Strele, ...
Allergy 64 (9), 1319-1326, 2009
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
NA Balenga, E Martínez‐Pinilla, J Kargl, R Schröder, M Peinhaupt, ...
British journal of pharmacology 171 (23), 5387-5406, 2014
Δ12-Prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis
A Heinemann, R Schuligoi, I Sabroe, A Hartnell, BA Peskar
The Journal of Immunology 170 (9), 4752-4758, 2003
Inflammation alters HDL composition and function: implications for HDL-raising therapies
G Marsche, MD Saemann, A Heinemann, M Holzer
Pharmacology & therapeutics 137 (3), 341-351, 2013
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human …
E Böhm, GJ Sturm, I Weiglhofer, H Sandig, M Shichijo, A McNamee, ...
Journal of Biological Chemistry 279 (9), 7663-7670, 2004
Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors
EM Sturm, P Schratl, R Schuligoi, V Konya, GJ Sturm, IT Lippe, BA Peskar, ...
The Journal of Immunology 181 (10), 7273-7283, 2008
Prostaglandin E2 suppresses human group 2 innate lymphoid cell function
J Maric, A Ravindran, L Mazzurana, ÅK Björklund, A Van Acker, A Rao, ...
Journal of Allergy and Clinical Immunology 141 (5), 1761-1773. e6, 2018
Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival
A Theiler, T Bärnthaler, W Platzer, G Richtig, M Peinhaupt, S Rittchen, ...
Journal of Allergy and Clinical Immunology 144 (3), 764-776, 2019
Aging affects high-density lipoprotein composition and function
M Holzer, M Trieb, V Konya, C Wadsack, A Heinemann, G Marsche
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2013
CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases
R Schuligoi, E Sturm, P Luschnig, V Konya, S Philipose, M Sedej, ...
Pharmacology 85 (6), 372-382, 2010
The system can't perform the operation now. Try again later.
Articles 1–20